BFM
MRSN

Boothbay Fund Management’s Mersana Therapeutics MRSN Stock Holding History

Boothbay Fund Management’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-13,622
Closed -$432K – 1906
2023
Q3 		$432K Buy
13,622
+13,221
+3,297% +$628K 0.01% 1098
2023
Q2 		$33K Buy
+401
New +$58.7K ﹤0.01% 1697
2021
Q4 		– Sell
-911
Closed -$215K – 2153
2021
Q3 		$215K Buy
911
+268
+42% +$78.3K 0.01% 1529
2021
Q2 		$218K Buy
+643
New +$243K 0.01% 1471
2021
Q1 		– Sell
-613
Closed -$297K – 1744
2020
Q4 		$408K Buy
+613
New +$341K 0.02% 830
2020
Q2 		– Sell
-484
Closed -$71K – 1089
2020
Q1 		$71K Buy
+484
New +$84.6K 0.01% 764

Other funds holding MRSN

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return